(3R,4R,5R)-5-(Acetoxymethyl)-3-methyltetrahydrofuran-2,3,4-triyl triacetate

Catalog No. :
ACMZUO638
CAS No. :
306960-25-8
Molecular Formula :
C14H20O9
Molecular Weight :
332.30

IUPAC Name:(3R,4R,5R)-5-(acetoxymethyl)-3-methyltetrahydrofuran-2,3,4-triyl triacetate

(3R,4R,5R)-5-(Acetoxymethyl)-3-methyltetrahydrofuran-2,3,4-triyl triacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,4R,5R)-5-(Acetoxymethyl)-3-methyltetrahydrofuran-2,3,4-triyl triacetate
IUPAC Name(3R,4R,5R)-5-(acetoxymethyl)-3-methyltetrahydrofuran-2,3,4-triyl triacetate
Molecular FormulaC14H20O9
Molecular Weight332.30
SMILESC[C@]1(OC(C)=O)C(OC(C)=O)O[C@H](COC(C)=O)[C@H]1OC(C)=O
InChI KeyRVXADQSOQHONLK-MVWAYNQESA-N
Synonym(3R,4R,5R)-5-(acetoxymethyl)-3-methyltetrahydrofuran-2,3,4-triyl triacetate;2-C-Methyl-D-ribofuranose tetraacetate;RVXADQSOQHONLK-MVWAYNQESA-N;2-C-methyl-1,2,3,5-tetra-O-acetyl-D-ribofuranose;D-Ribofuranose, 2-C-methyl-, tetraacetate (9CI)
CAS No.306960-25-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMZUO638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMZUO638 route product structure diagram
    ACMZUO638306960-25-8
Inquiry

2. ACMZUO638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMZUO638 route product structure diagram
    ACMZUO638306960-25-8
Inquiry

Comments (0)